APA (7th ed.) Citation

Zagórska, A., Bucki, A., Partyka, A., Jastrzębska-Więsek, M., Siwek, A., Głuch-Lutwin, M., . . . Kołaczkowski, M. (2022). Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia. European Journal of Medicinal Chemistry, 233, N.PAG. https://doi.org/10.1016/j.ejmech.2022.114218

Chicago Style (17th ed.) Citation

Zagórska, Agnieszka, et al. "Design, Synthesis, and Behavioral Evaluation of Dual-acting Compounds as Phosphodiesterase Type 10A (PDE10A) Inhibitors and Serotonin Ligands Targeting Neuropsychiatric Symptoms in Dementia." European Journal of Medicinal Chemistry 233 (2022): N.PAG. https://doi.org/10.1016/j.ejmech.2022.114218.

MLA (9th ed.) Citation

Zagórska, Agnieszka, et al. "Design, Synthesis, and Behavioral Evaluation of Dual-acting Compounds as Phosphodiesterase Type 10A (PDE10A) Inhibitors and Serotonin Ligands Targeting Neuropsychiatric Symptoms in Dementia." European Journal of Medicinal Chemistry, vol. 233, 2022, p. N.PAG, https://doi.org/10.1016/j.ejmech.2022.114218.